Antibiotic levels in lungs of healthy adults
Part of Infections clinical trials.
This trial tests how a new antibiotic (meropenem-pralubactam) moves into the lungs of healthy people in China. You will receive the medicine through an IV, and a lung fluid sample will be collected to measure the drug levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 28, and you weigh at least 50 kg (110 lbs).
- You have no lung or breathing problems, and your lung function tests are normal.
- You are not a smoker and have never smoked.
- You have not had a lung infection in the last 2 weeks.
- You are willing to undergo a bronchoscopy (a procedure to collect fluid from your lungs) and follow study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
This trial tests a combination of two antibiotics (meropenem and pralurbactam) to see if they work better than other treatments for people with pneumonia that started in the hospital or from a breathing machine. If you qualify, this study might offer you a new treatment option.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This trial tests a drug called Polymyxin E2 Methanesulfonate for a serious lung infection that patients can get in the hospital, caused by bacteria that don't respond to common antibiotics. It may be an option for people on ventilators or recently hospitalized with pneumonia that standard drugs can't treat.
This trial tests a new antibiotic called HRS-8427 for adults with bacterial pneumonia that started in the hospital or while on a ventilator. It may be an option if you need IV antibiotics and haven't already received long-term treatment for this infection.
This trial tests an investigational antibiotic called BAL2420 to see if it is safe and how the body processes it. Healthy volunteers are needed to help determine the right dose before it can be studied in people with infections.
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.